[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-ENOLASE).
PubMed=3529090 [NCBI, ExPASy, EBI, Israel, Japan]
Giallongo A.,
Feo S.,
Moore R.,
Croce C.M.,
Showe L.C.;
"Molecular cloning and nucleotide sequence of a full-length cDNA for human alpha enolase.";
Proc. Natl. Acad. Sci. U.S.A. 83:6741-6745(1986).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM ALPHA-ENOLASE).
TISSUE=T-cell;
PubMed=2373081 [NCBI, ExPASy, EBI, Israel, Japan]
Giallongo A.,
Oliva D.,
Cali L.,
Barba G.,
Barbieri G.,
Feo S.;
"Structure of the human gene for alpha-enolase.";
Eur. J. Biochem. 190:567-573(1990).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM MBP-1), AND FUNCTION.
TISSUE=Cervix carcinoma;
PubMed=2005901 [NCBI, ExPASy, EBI, Israel, Japan]
Ray R.,
Miller D.M.;
"Cloning and characterization of a human c-myc promoter-binding protein.";
Mol. Cell. Biol. 11:2154-2161(1991).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-ENOLASE), AND MARKER FOR ENDOMETRIOSIS.
TISSUE=Endometrium;
DOI=10.1016/S0896-8411(95)80027-1; PubMed=8824716 [NCBI, ExPASy, EBI, Israel, Japan]
Walter M.,
Berg H.,
Leidenberger F.A.,
Schweppe K.W.,
Northemann W.;
"Autoreactive epitopes within the human alpha-enolase and their recognition by sera from patients with endometriosis.";
J. Autoimmun. 8:931-945(1995).
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-ENOLASE).
TISSUE=Retina, and Stomach;
The German cDNA consortium;
Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LYS-177.
Livingston R.J.,
Rieder M.J.,
Shaffer T.,
Bertucci C.,
Baier C.N.,
Rajkumar N.,
Willa H.T.,
Daniels M.,
Downing T.K.,
Stanaway I.B.,
Nguyen C.P.,
Gildersleeve H.,
Cassidy C.M.,
Johnson E.J.,
Swanson J.E.,
McFarland I.,
Yool B.,
Park C.,
Nickerson D.A.;
"NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).";
Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
|
[7]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature04727; PubMed=16710414 [NCBI, ExPASy, EBI, Israel, Japan]
Gregory S.G.,
Barlow K.F.,
McLay K.E.,
Kaul R.,
Swarbreck D.,
Dunham A.,
Scott C.E.,
Howe K.L.,
Woodfine K.,
Spencer C.C.A.,
Jones M.C.,
Gillson C.,
Searle S.,
Zhou Y.,
Kokocinski F.,
McDonald L.,
Evans R.,
Phillips K.,
Atkinson A., ![]()
Cooper R.,
Jones C.,
Hall R.E.,
Andrews T.D.,
Lloyd C.,
Ainscough R.,
Almeida J.P.,
Ambrose K.D.,
Anderson F.,
Andrew R.W.,
Ashwell R.I.S.,
Aubin K.,
Babbage A.K.,
Bagguley C.L.,
Bailey J.,
Beasley H.,
Bethel G.,
Bird C.P.,
Bray-Allen S.,
Brown J.Y.,
Brown A.J.,
Buckley D.,
Burton J.,
Bye J.,
Carder C.,
Chapman J.C.,
Clark S.Y.,
Clarke G.,
Clee C.,
Cobley V.,
Collier R.E.,
Corby N.,
Coville G.J.,
Davies J.,
Deadman R.,
Dunn M.,
Earthrowl M.,
Ellington A.G.,
Errington H.,
Frankish A.,
Frankland J.,
French L.,
Garner P.,
Garnett J.,
Gay L.,
Ghori M.R.J.,
Gibson R.,
Gilby L.M.,
Gillett W.,
Glithero R.J.,
Grafham D.V.,
Griffiths C.,
Griffiths-Jones S.,
Grocock R.,
Hammond S.,
Harrison E.S.I.,
Hart E.,
Haugen E.,
Heath P.D.,
Holmes S.,
Holt K.,
Howden P.J.,
Hunt A.R.,
Hunt S.E.,
Hunter G.,
Isherwood J.,
James R.,
Johnson C.,
Johnson D.,
Joy A.,
Kay M.,
Kershaw J.K.,
Kibukawa M.,
Kimberley A.M.,
King A.,
Knights A.J.,
Lad H.,
Laird G.,
Lawlor S.,
Leongamornlert D.A.,
Lloyd D.M.,
Loveland J.,
Lovell J.,
Lush M.J.,
Lyne R.,
Martin S.,
Mashreghi-Mohammadi M.,
Matthews L.,
Matthews N.S.W.,
McLaren S.,
Milne S.,
Mistry S.,
Moore M.J.F.,
Nickerson T.,
O'Dell C.N.,
Oliver K.,
Palmeiri A.,
Palmer S.A.,
Parker A.,
Patel D.,
Pearce A.V.,
Peck A.I.,
Pelan S.,
Phelps K.,
Phillimore B.J.,
Plumb R.,
Rajan J.,
Raymond C.,
Rouse G.,
Saenphimmachak C.,
Sehra H.K.,
Sheridan E.,
Shownkeen R.,
Sims S.,
Skuce C.D.,
Smith M.,
Steward C.,
Subramanian S.,
Sycamore N.,
Tracey A.,
Tromans A.,
Van Helmond Z.,
Wall M.,
Wallis J.M.,
White S.,
Whitehead S.L.,
Wilkinson J.E.,
Willey D.L.,
Williams H.,
Wilming L.,
Wray P.W.,
Wu Z.,
Coulson A.,
Vaudin M.,
Sulston J.E.,
Durbin R.M.,
Hubbard T.,
Wooster R.,
Dunham I.,
Carter N.P.,
McVean G.,
Ross M.T.,
Harrow J.,
Olson M.V.,
Beck S.,
Rogers J.,
Bentley D.R.;
"The DNA sequence and biological annotation of human chromosome 1.";
Nature 441:315-321(2006).
|
[8]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-ENOLASE).
TISSUE=Brain, Eye, Lung, Ovary, Placenta, and Skin;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[9]
|
PROTEIN SEQUENCE OF 33-50; 163-179; 240-253 AND 307-326, AND MASS SPECTROMETRY.
TISSUE=Brain, and Cajal-Retzius cell;
Lubec G.,
Vishwanath V.;
Submitted (MAR-2007) to UniProtKB.
|
[10]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 166-434.
DOI=10.1006/geno.1997.5186; PubMed=9653645 [NCBI, ExPASy, EBI, Israel, Japan]
Onyango P.,
Lubyova B.,
Gardellin P.,
Kurzbauer R.,
Weith A.;
"Molecular cloning and expression analysis of five novel genes in chromosome 1p36.";
Genomics 50:187-198(1998).
|
[11]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 171-434.
TISSUE=Brain;
PubMed=9110174 [NCBI, ExPASy, EBI, Israel, Japan]
Yu W.,
Andersson B.,
Worley K.C.,
Muzny D.M.,
Ding Y.,
Liu W.,
Ricafrente J.Y.,
Wentland M.A.,
Lennon G.,
Gibbs R.A.;
"Large-scale concatenation cDNA sequencing.";
Genome Res. 7:353-358(1997).
|
[12]
|
PROTEIN SEQUENCE OF 2-9 (ISOFORM ALPHA-ENOLASE).
TISSUE=Colon carcinoma;
PubMed=9150948 [NCBI, ExPASy, EBI, Israel, Japan]
Ji H.,
Reid G.E.,
Moritz R.L.,
Eddes J.S.,
Burgess A.W.,
Simpson R.J.;
"A two-dimensional gel database of human colon carcinoma proteins.";
Electrophoresis 18:605-613(1997).
|
[13]
|
PROTEIN SEQUENCE OF 270-281 AND 307-321, AND INDUCTION IN DIFFUSE LARGE CELL LYMPHOMA.
PubMed=7787969 [NCBI, ExPASy, EBI, Israel, Japan]
Mohamad R.M.,
Hamdan M.Y.,
Maki A.,
Al-Katib A.;
"Induced expression of alpha-enolase in differentiated diffuse large cell lymphoma.";
Enzyme Protein 48:37-44(1995).
|
[14]
|
FUNCTION OF MBP1, IDENTIFICATION OF REPRESSOR DOMAINS, AND MUTAGENESIS OF LEU-384 AND LEU-388.
PubMed=10082554 [NCBI, ExPASy, EBI, Israel, Japan]
Ghosh A.K.,
Steele R.,
Ray R.B.;
"Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation.";
Mol. Cell. Biol. 19:2880-2886(1999).
|
[15]
|
FUNCTION AS A C-MYC TRANSCRIPTIONAL REPRESSOR, AND SUBCELLULAR LOCATION.
DOI=10.1016/S0014-5793(00)01494-0; PubMed=10802057 [NCBI, ExPASy, EBI, Israel, Japan]
Feo S.,
Arcuri D.,
Piddini E.,
Passantino R.,
Giallongo A.;
"ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1).";
FEBS Lett. 473:47-52(2000).
|
[16]
|
FUNCTION IN PLASMINOGEN ACTIVATION.
DOI=10.1002/ajh.10299; PubMed=12666133 [NCBI, ExPASy, EBI, Israel, Japan]
Lopez-Alemany R.,
Longstaff C.,
Hawley S.,
Mirshahi M.,
Fabregas P.,
Jardi M.,
Merton E.,
Miles L.A.,
Felez J.;
"Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-enolase.";
Am. J. Hematol. 72:234-242(2003).
|
[17]
|
INTERACTION WITH PLG.
PubMed=9308760 [NCBI, ExPASy, EBI, Israel, Japan]
Arza B.,
Felez J.,
Lopez-Alemany R.,
Miles L.A.,
Munoz-Canoves P.;
"Identification of an epitope of alpha-enolase (a candidate plasminogen receptor) by phage display.";
Thromb. Haemost. 78:1097-1103(1997).
|
[18]
|
EPITOPE MAPPING, AND ASSOCIATION WITH CAR.
DOI=10.1006/jaut.1998.0239; PubMed=9878089 [NCBI, ExPASy, EBI, Israel, Japan]
Adamus G.,
Amundson D.,
Seigel G.M.,
Machnicki M.;
"Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells.";
J. Autoimmun. 11:671-677(1998).
|
[19]
|
IDENTIFICATION OF MBP1 AS AN ALPHA-ENOLASE ALTERNATIVE INITIATION PRODUCT, AND MUTAGENESIS OF MET-94 AND MET-97.
DOI=10.1074/jbc.275.8.5958; PubMed=10681589 [NCBI, ExPASy, EBI, Israel, Japan]
Subramanian A.,
Miller D.M.;
"Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene.";
J. Biol. Chem. 275:5958-5965(2000).
|
[20]
|
REVIEW.
DOI=10.1007/PL00000910; PubMed=11497239 [NCBI, ExPASy, EBI, Israel, Japan]
Pancholi V.;
"Multifunctional alpha-enolase: its role in diseases.";
Cell. Mol. Life Sci. 58:902-920(2001).
|
[21]
|
INTERACTION OF MBP1 WITH SEDL.
DOI=10.1128/MCB.21.2.655-662.2001; PubMed=11134351 [NCBI, ExPASy, EBI, Israel, Japan]
Ghosh A.K.,
Majumder M.,
Steele R.,
White R.A.,
Ray R.B.;
"A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1.";
Mol. Cell. Biol. 21:655-662(2001).
|
[22]
|
IDENTIFICATION AS AN AUTOANTIGEN IN HASHIMOTO ENCEPHALOPATHY.
DOI=10.1016/S0014-5793(02)03307-0; PubMed=12297304 [NCBI, ExPASy, EBI, Israel, Japan]
Ochi H.,
Horiuchi I.,
Araki N.,
Toda T.,
Araki T.,
Sato K.,
Murai H.,
Osoegawa M.,
Yamada T.,
Okamura K.,
Ogino T.,
Mizumoto K.,
Yamashita H.,
Saya H.,
Kira J.;
"Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy.";
FEBS Lett. 528:197-202(2002).
|
[23]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-44 AND TYR-287, AND MASS SPECTROMETRY.
DOI=10.1038/nbt1046; PubMed=15592455 [NCBI, ExPASy, EBI, Israel, Japan]
Rush J.,
Moritz A.,
Lee K.A.,
Guo A.,
Goss V.L.,
Spek E.J.,
Zhang H.,
Zha X.-M.,
Polakiewicz R.D.,
Comb M.J.;
"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
Nat. Biotechnol. 23:94-101(2005).
|
[24]
|
ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-71, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1016/j.molcel.2006.06.026; PubMed=16916647 [NCBI, ExPASy, EBI, Israel, Japan]
Kim S.C.,
Sprung R.,
Chen Y.,
Xu Y.,
Ball H.,
Pei J.,
Cheng T.,
Kho Y.,
Xiao H.,
Xiao L.,
Grishin N.V.,
White M.,
Yang X.-J.,
Zhao Y.;
"Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.";
Mol. Cell 23:607-618(2006).
|
[25]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-44 AND TYR-287, AND MASS SPECTROMETRY.
DOI=10.1016/j.cell.2007.11.025; PubMed=18083107 [NCBI, ExPASy, EBI, Israel, Japan]
Rikova K.,
Guo A.,
Zeng Q.,
Possemato A.,
Yu J.,
Haack H.,
Nardone J.,
Lee K.,
Reeves C.,
Li Y.,
Hu Y.,
Tan Z.,
Stokes M.,
Sullivan L.,
Mitchell J.,
Wetzel R.,
Macneill J.,
Ren J.M.,
Yuan J., ![]()
Bakalarski C.E.,
Villen J.,
Kornhauser J.M.,
Smith B.,
Li D.,
Zhou X.,
Gygi S.P.,
Gu T.-L.,
Polakiewicz R.D.,
Rush J.,
Comb M.J.;
"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.";
Cell 131:1190-1203(2007).
|
[26]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-72, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1021/pr070152u; PubMed=17924679 [NCBI, ExPASy, EBI, Israel, Japan]
Yu L.-R.,
Zhu Z.,
Chan K.C.,
Issaq H.J.,
Dimitrov D.S.,
Veenstra T.D.;
"Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
J. Proteome Res. 6:4150-4162(2007).
|
[27]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-57 AND SER-63, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0611217104; PubMed=17287340 [NCBI, ExPASy, EBI, Israel, Japan]
Molina H.,
Horn D.M.,
Tang N.,
Mathivanan S.,
Pandey A.;
"Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.";
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
|
|
ExPASy Home page
